tiprankstipranks
10x Genomics Inc (TXG)
NASDAQ:TXG
US Market
TXG
10x Genomics
RESEARCH TOOLSreports
Want to see TXG full AI Analyst Report?

10x Genomics (TXG) Ratios

1,285 Followers

10x Genomics Ratios

TXG's free cash flow for Q2 2026 was $0.74. For the 2026 fiscal year, TXG's free cash flow was decreased by $ and operating cash flow was $-0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.69 4.46 4.97 4.69 4.85
Quick Ratio
 5.25 4.09 4.26 4.11 4.23
Cash Ratio
 4.24 3.09 2.92 2.83 1.68
Solvency Ratio
 -0.19 <0.01 -0.67 -0.94 -0.60
Operating Cash Flow Ratio
 1.07 0.89 0.06 -0.12 -0.26
Short-Term Operating Cash Flow Coverage
 10.58 12.39 0.00 0.00 0.00
Net Current Asset Value
$ 470.15M$ 439.41M$ 375.88M$ 371.92M$ 411.80M
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.15 0.09 0.10 0.09
Debt-to-Equity Ratio
 0.10 0.20 0.12 0.13 0.12
Debt-to-Capital Ratio
 0.09 0.17 0.10 0.11 0.11
Long-Term Debt-to-Capital Ratio
 0.00 0.08 0.00 0.00 0.00
Financial Leverage Ratio
 1.25 1.31 1.29 1.30 1.28
Debt Service Coverage Ratio
 2.31 0.02 -34.73K -6.41K -278.40
Interest Coverage Ratio
 -29.46K 0.00 -48.64K -8.04K -352.82
Debt to Market Cap
 <0.01 0.04 0.00 0.00 0.00
Interest Debt Per Share
 0.61 1.26 0.69 0.81 0.84
Net Debt to EBITDA
 -15.13 -80.90 1.95 1.29 0.97
Profitability Margins
Gross Profit Margin
70.03%69.05%67.86%66.15%76.69%
EBIT Margin
-1.34%-6.21%-29.09%-40.20%-31.27%
EBITDA Margin
4.54%0.61%-21.94%-33.15%-24.88%
Operating Profit Margin
-14.33%-17.25%-31.85%-42.88%-32.52%
Pretax Profit Margin
-12.14%-6.21%-29.09%-40.21%-31.36%
Net Profit Margin
-12.18%-6.77%-29.90%-41.23%-32.15%
Continuous Operations Profit Margin
-12.18%-6.77%-29.90%-41.23%-32.15%
Net Income Per EBT
100.31%109.11%102.77%102.55%102.49%
EBT Per EBIT
84.73%35.99%91.33%93.76%96.44%
Return on Assets (ROA)
-7.29%-4.18%-19.88%-26.43%-16.13%
Return on Equity (ROE)
-9.33%-5.47%-25.72%-34.42%-20.60%
Return on Capital Employed (ROCE)
-9.70%-12.49%-24.29%-31.66%-18.70%
Return on Invested Capital (ROIC)
-9.57%-12.34%-24.01%-31.23%-18.52%
Return on Tangible Assets
-7.81%-4.47%-20.33%-27.02%-16.57%
Earnings Yield
-0.84%-2.14%-10.56%-3.89%-4.00%
Efficiency Ratios
Receivables Turnover
 12.18 7.79 6.95 5.39 4.96
Payables Turnover
 8.93 15.62 15.21 13.31 5.57
Inventory Turnover
 3.51 3.53 2.36 2.84 1.47
Fixed Asset Turnover
 2.27 2.24 1.97 1.79 1.44
Asset Turnover
 0.60 0.62 0.66 0.64 0.50
Working Capital Turnover Ratio
 1.11 1.29 1.31 1.27 0.90
Cash Conversion Cycle
 92.98 126.85 183.03 168.78 255.66
Days of Sales Outstanding
 29.96 46.84 52.51 67.74 73.66
Days of Inventory Outstanding
 103.88 103.37 154.53 128.47 247.49
Days of Payables Outstanding
 40.85 23.36 24.00 27.43 65.49
Operating Cycle
 133.83 150.21 207.03 196.21 321.15
Cash Flow Ratios
Operating Cash Flow Per Share
 0.98 1.09 0.06 -0.13 -0.30
Free Cash Flow Per Share
 0.93 1.04 -0.05 -0.55 -1.45
CapEx Per Share
 0.04 0.05 0.10 0.42 1.16
Free Cash Flow to Operating Cash Flow
 0.96 0.96 -0.86 4.26 4.92
Dividend Paid and CapEx Coverage Ratio
 22.50 22.92 0.54 -0.31 -0.26
Capital Expenditure Coverage Ratio
 22.50 22.92 0.54 -0.31 -0.26
Operating Cash Flow Coverage Ratio
 1.61 0.86 0.08 -0.16 -0.35
Operating Cash Flow to Sales Ratio
 0.21 0.21 0.01 -0.02 -0.07
Free Cash Flow Yield
1.39%6.39%-0.33%-0.99%-3.98%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -116.25 -46.60 -9.45 -25.70 -24.99
Price-to-Sales (P/S) Ratio
 14.12 3.17 2.83 10.60 8.03
Price-to-Book (P/B) Ratio
 10.80 2.56 2.44 8.85 5.15
Price-to-Free Cash Flow (P/FCF) Ratio
 71.71 15.64 -301.92 -101.30 -25.10
Price-to-Operating Cash Flow Ratio
 70.15 14.96 259.56 -431.44 -123.46
Price-to-Earnings Growth (PEG) Ratio
 0.25 0.61 0.31 -0.52 -0.14
Price-to-Fair Value
 10.80 2.56 2.44 8.85 5.15
Enterprise Value Multiple
 295.82 439.61 -10.96 -30.68 -31.32
Enterprise Value
 8.28B 1.72B 1.47B 6.29B 4.02B
EV to EBITDA
 295.82 439.61 -10.96 -30.68 -31.32
EV to Sales
 13.43 2.67 2.40 10.17 7.79
EV to Free Cash Flow
 68.22 13.21 -256.28 -97.23 -24.35
EV to Operating Cash Flow
 65.19 12.63 220.32 -414.07 -119.75
Tangible Book Value Per Share
 5.83 5.85 5.73 6.14 6.84
Shareholders’ Equity Per Share
 6.35 6.38 5.90 6.32 7.08
Tax and Other Ratios
Effective Tax Rate
 >-0.01 -0.09 -0.03 -0.03 -0.02
Revenue Per Share
 4.75 5.15 5.07 5.28 4.54
Net Income Per Share
 -0.58 -0.35 -1.52 -2.18 -1.46
Tax Burden
 1.00 1.09 1.03 1.03 1.02
Interest Burden
 9.07 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.37 0.37 0.43 0.44 0.51
SG&A to Revenue
 0.48 0.49 0.56 0.00 0.57
Stock-Based Compensation to Revenue
 0.16 0.17 0.23 0.27 0.26
Income Quality
 -1.69 -3.12 -0.04 0.06 0.20
Currency in USD